Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Calhoun

Showing results (121-130 of 188) with videos related to

Pageof 19
Sort By:
Chest|January 5, 2013
Increased dietary sodium is related to severity of obstructive sleep apnea in patients with resistant hypertension and hyperaldosteronismEduardo Pimenta, Michael Stowasser, Richard D Gordon, et al.
Blood Pressure Monitoring|December 20, 2019
Blood pressure monitoring in sleep: time to wake upYounghoon Kwon, Patrick L Stafford, Diane C Lim, et al.
American Journal of Hypertension|August 20, 2020
Uric Acid Is Not Associated With Blood Pressure Phenotypes and Target Organ Damage According to Blood Pressure PhenotypesAnping Cai, Lin Liu, Mohammed Siddiqui, et al.
Chest|February 14, 2007
Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertensionMonique N Pratt-Ubunama, Mari K Nishizaka, Robyn L Boedefeld, et al.
Hypertension (Dallas, Tex. : 1979)|February 5, 2014
Response to Comment on optimal treatment for resistant hypertension: the missing data on pulse wave velocityBrent M Egan, Yumin Zhao, Jiexiang Li, et al.
Circulation|October 12, 2011
Effects of a novel aldosterone synthase inhibitor for treatment of primary hypertension: results of a randomized, double-blind, placebo- and active-controlled phase 2 trialDavid A Calhoun, William B White, Henry Krum, et al.
Hypertension (Dallas, Tex. : 1979)|August 7, 2013
Prevalence of optimal treatment regimens in patients with apparent treatment-resistant hypertension based on office blood pressure in a community-based practice networkBrent M Egan, Yumin Zhao, Jiexiang Li, et al.
Annals of Internal Medicine|May 26, 2020
The Unrecognized Prevalence of Primary Aldosteronism: A Cross-sectional StudyJenifer M Brown, Mohammed Siddiqui, David A Calhoun, et al.
Hypertension (Dallas, Tex. : 1979)|July 23, 2019
Masked Uncontrolled Hypertension Is Not Attributable to Medication NonadherenceMohammed Siddiqui, Eric K Judd, Tanja Dudenbostel, et al.
Journal of Hypertension|May 7, 2019
Prevalence of refractory hypertension in the United States from 1999 to 2014Michael G Buhnerkempe, Albert Botchway, Vivek Prakash, et al.
Pageof 19

Showing results (121-130 of 188) with videos related to

Sort By:
Pageof 19
Chest|January 5, 2013
Increased dietary sodium is related to severity of obstructive sleep apnea in patients with resistant hypertension and hyperaldosteronismEduardo Pimenta, Michael Stowasser, Richard D Gordon, et al.
Blood Pressure Monitoring|December 20, 2019
Blood pressure monitoring in sleep: time to wake upYounghoon Kwon, Patrick L Stafford, Diane C Lim, et al.
American Journal of Hypertension|August 20, 2020
Uric Acid Is Not Associated With Blood Pressure Phenotypes and Target Organ Damage According to Blood Pressure PhenotypesAnping Cai, Lin Liu, Mohammed Siddiqui, et al.
Chest|February 14, 2007
Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertensionMonique N Pratt-Ubunama, Mari K Nishizaka, Robyn L Boedefeld, et al.
Hypertension (Dallas, Tex. : 1979)|February 5, 2014
Response to Comment on optimal treatment for resistant hypertension: the missing data on pulse wave velocityBrent M Egan, Yumin Zhao, Jiexiang Li, et al.
Circulation|October 12, 2011
Effects of a novel aldosterone synthase inhibitor for treatment of primary hypertension: results of a randomized, double-blind, placebo- and active-controlled phase 2 trialDavid A Calhoun, William B White, Henry Krum, et al.
Hypertension (Dallas, Tex. : 1979)|August 7, 2013
Prevalence of optimal treatment regimens in patients with apparent treatment-resistant hypertension based on office blood pressure in a community-based practice networkBrent M Egan, Yumin Zhao, Jiexiang Li, et al.
Annals of Internal Medicine|May 26, 2020
The Unrecognized Prevalence of Primary Aldosteronism: A Cross-sectional StudyJenifer M Brown, Mohammed Siddiqui, David A Calhoun, et al.
Hypertension (Dallas, Tex. : 1979)|July 23, 2019
Masked Uncontrolled Hypertension Is Not Attributable to Medication NonadherenceMohammed Siddiqui, Eric K Judd, Tanja Dudenbostel, et al.
Journal of Hypertension|May 7, 2019
Prevalence of refractory hypertension in the United States from 1999 to 2014Michael G Buhnerkempe, Albert Botchway, Vivek Prakash, et al.
Pageof 19